Solace Therapeutics Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Out of Business

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Out of Business

Solace Therapeutics General Information

Description

Developer of non-surgical devices designed to treat common bladder disorders. The company's devices are small and lightweight and float within the urinary bladder to treat complications such as stress urinary incontinence (SUI), overactive bladder (OAB), male voiding dysfunction and lower urinary tract symptoms (LUTS), enabling patients to have a non-surgical alternative to involuntary urinary leakage.

Contact Information

Website
www.solacetx.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 135 Newbury Street
  • Framingham, MA 01701
  • United States
+1 (508)
Primary Industry
Therapeutic Devices
Vertical(s)
LOHAS & Wellness, HealthTech
Corporate Office
  • 135 Newbury Street
  • Framingham, MA 01701
  • United States
+1 (508)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Solace Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Out of Business Completed Generating Revenue
8. Secondary Transaction - Private 01-Mar-2021 Completed Generating Revenue
7. Debt - PPP 13-Apr-2020 Completed Generating Revenue
6. Later Stage VC (Series 2) 12-Feb-2020 Completed Generating Revenue
5. Later Stage VC (Series 1) 11-Feb-2019 Completed Generating Revenue
4. Later Stage VC (Series C) 06-Sep-2016 Completed Clinical Trials - Phase 4
3. Later Stage VC (Series B) 31-Dec-2013 Completed Clinical Trials - Phase 4
2. Later Stage VC 28-Mar-2012 $7M $10M Completed Generating Revenue
1. Later Stage VC (Series B2) 13-Jul-2006 $3M $3M Completed Startup
To view Solace Therapeutics’s complete valuation and funding history, request access »

Solace Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series 2-A
Series 2
Series 1 19,277,780 $0.001000 8% $0.1 $0.1 1x $0.1 15.12%
To view Solace Therapeutics’s complete cap table history, request access »

Solace Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of non-surgical devices designed to treat common bladder disorders. The company's devices are small and lightw
Therapeutic Devices
Framingham, MA
10 As of 2022

Plymouth, MN
 

Newton, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Solace Therapeutics Competitors (5)

One of Solace Therapeutics’s 5 competitors is Uromedica, a Formerly VC-backed company based in Plymouth, MN.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Uromedica Formerly VC-backed Plymouth, MN
Lumicell Venture Capital-Backed Newton, MA
Inari Medical Formerly VC-backed Irvine, CA
Viveve Medical Formerly VC-backed Englewood, CO
Kimberly-Clark Corporation Dallas, TX
You’re viewing 5 of 5 competitors. Get the full list »

Solace Therapeutics Patents

  • 105

    Total Documents Applications and Grants

  • Total Patents Families

  • 41

    Granted

  • Pending

  • Expiring in next 12 mo

Solace Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3920771-A1 Pressure attenuation device Inactive 07-Feb-2019
EP-3920771-A4 Pressure attenuation device Inactive 07-Feb-2019
US-11197981-B2 Pressure attenuation device Inactive 07-Feb-2019
US-20200254226-A1 Pressure attenuation device Inactive 07-Feb-2019
US-20200324091-A1 Pressure attenuation device Active 07-Feb-2019 A61M25/10
To view Solace Therapeutics’s complete patent history, request access »

Solace Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Solace Therapeutics FAQs

  • When was Solace Therapeutics founded?

    Solace Therapeutics was founded in 1996.

  • Where is Solace Therapeutics headquartered?

    Solace Therapeutics is headquartered in Framingham, MA.

  • What is the size of Solace Therapeutics?

    Solace Therapeutics has 10 total employees.

  • What industry is Solace Therapeutics in?

    Solace Therapeutics’s primary industry is Therapeutic Devices.

  • Is Solace Therapeutics a private or public company?

    Solace Therapeutics is a Private company.

  • What is Solace Therapeutics’s current revenue?

    The current revenue for Solace Therapeutics is .

  • How much funding has Solace Therapeutics raised over time?

    Solace Therapeutics has raised $61.4M.

  • Who are Solace Therapeutics’s competitors?

    Uromedica, Lumicell, Inari Medical, Viveve Medical, and Kimberly-Clark are competitors of Solace Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process